Donor-Transmitted Cancer in Orthotopic Solid Organ Transplant Recipients: A Systematic Review
暂无分享,去创建一个
Rachel J. Johnson | L. Tomlinson | S. Brunskill | C. Watson | C. Callaghan | M. Ibrahim | G. Greenhall | Utkarsh Dutta | C. Dorée | George H B Greenhall
[1] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.
[2] E. Mayo-Wilson,et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. , 2021, Journal of clinical epidemiology.
[3] U. Boggi,et al. Donor‐Transmitted Cancers in Transplanted Livers: Analysis of Clinical Outcomes , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] Cameron R. Wolfe,et al. Ten years of donor‐derived disease: A report of the disease transmission advisory committee , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] U. Boggi,et al. Donor-transmitted cancer in kidney transplant recipients: a systematic review , 2020, Journal of Nephrology.
[6] V. Welch,et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline , 2020, BMJ.
[7] J. Popic,et al. Liver re-transplantation for donor-derived neuroendocrine tumor: A case report , 2019, World journal of clinical cases.
[8] T. Luedde,et al. A liver nodule in a patient transplanted for primary sclerosing cholangitis: an interdisciplinary diagnostic approach , 2016, Zeitschrift für Gastroenterologie.
[9] A. Amoroso,et al. Successful Urgent Liver Retransplantation for Donor‐Transmitted Hepatocellular Carcinoma , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] C. Tufanaru,et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data , 2015, International journal of evidence-based healthcare.
[11] P. Macdonald,et al. Ethical Guidelines for Organ Transplantation from Deceased Donors. , 2015, Heart, lung & circulation.
[12] R. Girlanda,et al. Isolated Peritoneal Donor‐Related Plasmacytoma 3 Years After Liver Transplantation: A Case Report , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] J. Craig,et al. Donor Cancer Transmission in Kidney Transplantation: A Systematic Review , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] J. Neuberger,et al. Cancer Transmission From Organ Donors—Unavoidable But Low Risk , 2012, Transplantation.
[15] E. S. de Mello,et al. Transmission of clear cell tumor in a graft liver from cadaveric donor: Case report , 2012, Pediatric transplantation.
[16] W. Grigioni,et al. The use of neoplastic donors to increase the donor pool. , 2012, Transplantation proceedings.
[17] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[18] M. Gaub,et al. Post‐transplant Lymphoproliferative Disorders: Determination of Donor/Recipient Origin in a Large Cohort of Kidney Recipients , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] M. Ison,et al. An Update on Donor‐Derived Disease Transmission in Organ Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] J. DiMaio,et al. Donor‐Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] K. Halling,et al. Retransplantation for donor‐derived neuroendocrine tumor , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] J. Bradley,et al. How Safe Is It to Transplant Organs from Deceased Donors with Primary Intracranial Malignancy? An Analysis of UK Registry Data , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] R. Cardigan,et al. Advisory Committee on the Safety of Blood, Tissues and Organs , 2009, Transfusion medicine.
[24] R. Matesanz,et al. The Spanish National Transplant Organization (ONT) Tumor Registry , 2008, Transplantation.
[25] J. O'grady,et al. Donor‐transmitted malignancy confirmed by quantitative fluorescence polymerase chain reaction genotype analysis: A rare indication for liver retransplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] Jorge Ortiz,et al. Extended Survival by Urgent Liver Retransplantation after Using a First Graft with Metastasis from Initially Unrecognized Donor Sarcoma , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] S. Thung,et al. Unresectable Squamous Cell Carcinoma of Donor Origin Treated With Immunosuppression Withdrawal and Liver Retransplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] O. Thomusch,et al. Transmission of a pancreatic adenocarcinoma to a renal transplant recipient , 2003, Clinical transplantation.
[29] K. Jones,et al. Death from donor‐transmitted malignancy despite emergency liver retransplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[30] F. Delmonico,et al. Donor-related malignancies , 2002 .
[31] W. Marks,et al. Transplant tumor registry: donor related malignancies , 2002, Transplantation.
[32] S. Kakar,et al. Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. , 2002, Human pathology.
[33] B. Petit,et al. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation. , 2002, Transplantation.
[34] H. Rilo,et al. Transmission of donor cancer into cardiothoracic transplant recipients. , 2001, Surgery.
[35] W. Grody,et al. Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. , 1997, Transplantation.
[36] J. Concato,et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. , 1995, Journal of clinical epidemiology.
[37] R. Wilson,et al. Immunologic rejection of human cancer transplanted with a renal allograft. , 1968, The New England journal of medicine.
[38] C. Tufanaru,et al. Chapter 7: Systematic Reviews of Etiology and Risk , 2020, JBI Manual for Evidence Synthesis.
[39] D. C. Henckel,et al. Case report. , 1995, Journal.
[40] C. Zukoski,et al. Transplanted carcinoma in an immunosuppressed patient. , 1970, Transplantation.